Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 2004 Nov;63(Suppl 2):ii40–ii45. doi: 10.1136/ard.2004.028233

The International Classification of Functioning, Disability and Health (ICF) Core Sets for rheumatoid arthritis: a way to specify functioning

G Stucki, A Cieza
PMCID: PMC1766771  PMID: 15479870

Abstract

Today, patients' functioning is a central issue in medicine. Concepts, classifications, and measurements of functioning and health, such as the International Classification of Functioning, Disability and Health (ICF) are of prime importance in clinical practice, teaching, and research. This report compares the contents of three of the most widely used health status measures in rheumatoid arthritis (RA), namely the Health Assessment Questionnaire disability index (HAQ), the Arthritis Impact Measurement Scales 2 (AIMS2), and the Short Form health survey (SF-36) based on the ICF. In addition, their content is compared to the Comprehensive ICF Core Set for RA.

The comparisons illustrate that the different health status measures cover different components, and that they cover the different components with different level of precision. Using the ICF as a reference framework allows a researcher or a recommending instance to see which domains are covered in a specific instrument and, therefore, whether it is necessary to complement the study with other measures. Nevertheless, which specific health status measures to recommend still remains a challenge. If enough care is taken to define "what should be measured", it could form the basis for a solid and stable recommendation, adhered to for many years.

Full Text

The Full Text of this article is available as a PDF (75.9 KB).

Figure 1.

Figure 1

Open in a new tab

 The current framework of disability—World Health Organization International Classification of Functioning, Disability and Health (ICF).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., Healey L. A., Kaplan S. R., Liang M. H., Luthra H. S. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988 Mar;31(3):315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  2. Boers M., Tugwell P., Felson D. T., van Riel P. L., Kirwan J. R., Edmonds J. P., Smolen J. S., Khaltaev N., Muirden K. D. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl. 1994 Sep;41:86–89. [PubMed] [Google Scholar]
  3. Chino Naoichi, Ishigami Shigenobu, Akai Masami, Liu Meigen, Okajima Yasutomo, Koike Junko, Kobayashi Kazushige. Current status of rehabilitation medicine in Asia: a report from New Millennium Asian Symposium on Rehabilitation Medicine. J Rehabil Med. 2002 Jan;34(1):1–4. doi: 10.1080/165019702317242631. [DOI] [PubMed] [Google Scholar]
  4. Felson D. T., Anderson J. J., Boers M., Bombardier C., Chernoff M., Fried B., Furst D., Goldsmith C., Kieszak S., Lightfoot R. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 1993 Jun;36(6):729–740. doi: 10.1002/art.1780360601. [DOI] [PubMed] [Google Scholar]
  5. Fries J. F., Spitz P., Kraines R. G., Holman H. R. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980 Feb;23(2):137–145. doi: 10.1002/art.1780230202. [DOI] [PubMed] [Google Scholar]
  6. McHorney C. A. Generic health measurement: past accomplishments and a measurement paradigm for the 21st century. Ann Intern Med. 1997 Oct 15;127(8 Pt 2):743–750. doi: 10.7326/0003-4819-127-8_part_2-199710151-00061. [DOI] [PubMed] [Google Scholar]
  7. Meenan R. F., Gertman P. M., Mason J. H. Measuring health status in arthritis. The arthritis impact measurement scales. Arthritis Rheum. 1980 Feb;23(2):146–152. doi: 10.1002/art.1780230203. [DOI] [PubMed] [Google Scholar]
  8. Meenan R. F., Mason J. H., Anderson J. J., Guccione A. A., Kazis L. E. AIMS2. The content and properties of a revised and expanded Arthritis Impact Measurement Scales Health Status Questionnaire. Arthritis Rheum. 1992 Jan;35(1):1–10. doi: 10.1002/art.1780350102. [DOI] [PubMed] [Google Scholar]
  9. Stucki G., Cieza A., Ewert T., Kostanjsek N., Chatterji S., Ustün T. Bedirhan. Application of the International Classification of Functioning, Disability and Health (ICF) in clinical practice. Disabil Rehabil. 2002 Mar 20;24(5):281–282. doi: 10.1080/09638280110105222. [DOI] [PubMed] [Google Scholar]
  10. Stucki Gerold, Ewert Thomas, Cieza Alarcos. Value and application of the ICF in rehabilitation medicine. Disabil Rehabil. 2003 Jun 3;25(11-12):628–634. doi: 10.1080/09638280110070221. [DOI] [PubMed] [Google Scholar]
  11. Tugwell P., Boers M. Developing consensus on preliminary core efficacy endpoints for rheumatoid arthritis clinical trials. OMERACT Committee. J Rheumatol. 1993 Mar;20(3):555–556. [PubMed] [Google Scholar]
  12. Ware J. E., Jr, Sherbourne C. D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992 Jun;30(6):473–483. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES